Curosurf (poractant alfa) for the treatment of infants at risk for or experiencing respiratory distress syndrome a review of clinical effectiveness, cost-effectiveness, and guidelines
The leading cause of respiratory distress syndrome in premature infants is the lack of surfactant. Surfactant is secreted by the cells in pulmonary alveoli and decrease the surface tension in the aveoli. The secretion of surfactant in fetus lungs begins at the third trimester of pregnancy. With surf...
| Main Authors: | , |
|---|---|
| Corporate Authors: | , |
| Format: | eBook |
| Language: | English |
| Published: |
Ottawa
CADTH
September 18, 2018, 2018
|
| Series: | CADTH rapid response report: summary with critical appraisal
|
| Online Access: | |
| Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
Table of Contents:
- Includes bibliographical references